45 CFR § 180 compliance
A · 100
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,807
Insurances with rates
7
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 27644 | Pegloticase 8 Mg/ml Sol | $72,054 | $36,027 | $2,719 | $69,172 | 8 |
| 7330325 | Ravulizumab 100 Mg/ml Sol | $57,482 | $28,741 | $2,719 | $55,183 | 8 |
| 27646 | Ocrelizumab 300 Mg/10 Ml Sol | $49,538 | $24,769 | $2,719 | $47,556 | 8 |
| 26997 | Leuprolide 45 Mg/6 Months Pwd | $30,907 | $15,454 | $2,719 | $29,671 | 8 |
| CP17497697282310369 | Major joint replacement or reattachment of lower extremity without MCC | $29,578 | $14,789 | $2,719 | $28,395 | 7 |
| 7330382 | Pembrolizumab 25 Mg/ml Sol | $28,309 | $14,155 | $2,719 | $27,177 | 8 |
| 7330404 | Cemiplimab Rwlc 350 Mg/7 Ml Sol | $27,203 | $13,602 | $2,719 | $26,115 | 8 |
| 7330329 | Ublituximab Xiiy 150 Mg/6 Ml Sol | $26,664 | $13,332 | $2,719 | $25,597 | 8 |
| 7330320 | Risankizumab Rzaa 60 Mg/ml Sol | $24,894 | $12,447 | $2,701 | $23,898 | 8 |
| 7330386 | Daratumumab-hyaluronidase Fihj 1800 Mg-30,000 Units/15 Ml Sol | $24,054 | $12,027 | $2,610 | $23,092 | 8 |
| 7330405 | Octreotide 20 Mg Pwd | $23,266 | $11,633 | $2,524 | $22,335 | 8 |
| 7330290 | Lanreotide 120 Mg/0.5 Ml Sol | $22,949 | $11,475 | $2,490 | $22,031 | 8 |
| 73301 | Vedolizumab 300 Mg Pow | $22,464 | $11,232 | $2,437 | $21,565 | 8 |
| CP17497697282303147 | Shaving of shoulder bone using endoscope | $22,364 | $11,182 | $2,426 | $21,469 | 7 |
| CP17497697282313237 | Uterine and adnexa procedures for non-malignancy without CC or MCC | $21,471 | $10,736 | $2,719 | $20,612 | 7 |
| 25168 | Alteplase 1mg [Swmh] | $21,121 | $10,561 | $2,292 | $20,276 | 8 |
| 27569 | Leuprolide 30 Mg/4 Months Kit | $20,604 | $10,302 | $2,236 | $19,780 | 8 |
| 25684 | Natalizumab 300 Mg/15 Ml Con | $20,491 | $10,246 | $2,223 | $19,671 | 8 |
| 7330139 | Tenecteplase 50 Mg Pow | $19,913 | $9,957 | $2,161 | $19,116 | 8 |
| CP17497697282300449 | Removal of one knee cartilage using an endoscope | $19,804 | $9,902 | $2,149 | $19,012 | 7 |
| CP17497697282314035 | Removal of gallbladder using an endoscope | $19,164 | $9,582 | $2,079 | $18,397 | 7 |
| 7330242 | Immune Globulin Intravenous 10% Sol | $18,416 | $9,208 | $1,998 | $17,679 | 8 |
| CP17497697282319655 | Spinal fusion except cervical without MCC | $18,379 | $9,190 | $2,719 | $17,644 | 7 |
| 7330131 | Dantrolene 250 Mg Pow | $16,704 | $8,352 | $1,812 | $16,036 | 8 |
| 7330400 | Pertuzumab 420 Mg/14 Ml Sol | $16,369 | $8,185 | $1,776 | $15,714 | 8 |
| 7330237 | Ferric Derisomaltose 100 Mg/ml Sol | $16,364 | $8,182 | $1,775 | $15,709 | 8 |
| 26326 | Leuprolide 22.5 Mg/3 Months Pwd | $15,453 | $7,727 | $1,677 | $14,835 | 8 |
| 26143 | Pegfilgrastim 6 Mg/0.6 Ml Sol | $15,403 | $7,702 | $1,671 | $14,787 | 8 |
| CP17497697282311289 | Repair of groin hernia patient age 5 years or older | $15,189 | $7,595 | $1,648 | $14,581 | 7 |
| 26942 | Certolizumab 200 Mg/ml Kit | $14,399 | $7,200 | $1,562 | $13,823 | 8 |
| 27564 | Benralizumab 30 Mg/ml Sol | $13,624 | $6,812 | $1,478 | $13,079 | 8 |
| 7330407 | Romiplostim 500 Mcg Pow | $13,214 | $6,607 | $1,434 | $12,685 | 8 |
| 26332 | Leuprolide 11.25 Mg/3 Months Pwd | $12,968 | $6,484 | $1,407 | $12,449 | 8 |
| 27132 | Conversion Of Previous Hip Surgery To Total Hip Arthroplasty, With Or Without Autograft Or Allograft | $12,893 | $6,447 | $1,399 | $12,377 | 7 |
| 685027268 | 27268 Closed Treatment Of Femoral Fracture, Proximal End, Head; With Manipulation | $12,811 | $6,406 | $1,390 | $12,299 | 7 |
| 733012 | Coagulation Factor Xa Recombinant, Inactivated 200 Mg Pow | $12,600 | $6,300 | $1,367 | $12,096 | 8 |
| 7330212 | Immune Globulin Intravenous And Subcutaneous 10% Sol | $12,572 | $6,286 | $1,364 | $12,069 | 8 |
| 26974 | Idarucizumab 2.5 G/50 Ml Sol | $12,246 | $6,123 | $1,329 | $11,756 | 8 |
| 25564 | Digoxin Immune 40mg [Swmh] | $11,938 | $5,969 | $1,295 | $11,460 | 8 |
| 27568 | Triptorelin 22.5 Mg/6 Months Pow | $11,711 | $5,856 | $1,271 | $11,243 | 8 |
| 25678 | Rituximab 10 Mg/ml Sol | $11,274 | $5,637 | $1,223 | $10,823 | 8 |
| 7330359 | Hyaluronidase-trastuzumab 10,000 Units-600 Mg/5 Ml Sol | $11,221 | $5,611 | $1,217 | $10,772 | 8 |
| 36145 | Radiofrequency Ablation Saphenous Vein Ablation, Second Vein | $10,995 | $5,498 | $1,193 | $10,555 | 7 |
| 26712 | Trastuzumab 440 Mg Pow | $10,971 | $5,486 | $1,190 | $10,532 | 8 |
| 7330122 | Basiliximab 20 Mg Pow | $10,942 | $5,471 | $1,187 | $10,504 | 8 |
| 26049 | Leuprolide 15 Mg/month Pwd | $10,398 | $5,199 | $1,128 | $9,982 | 8 |
| 733052 | C1 Esterase Inhibitor, Human 500 Intl Units Kit | $10,252 | $5,126 | $1,112 | $9,842 | 8 |
| 7330355 | Rituximab Abbs 10 Mg/ml Sol | $10,147 | $5,074 | $1,101 | $9,741 | 8 |
| 7330395 | Pegfilgrastim Cbqv 6 Mg/0.6 Ml Sol | $10,020 | $5,010 | $1,087 | $9,619 | 8 |
| 7330373 | Durvalumab 50 Mg/ml Sol | $9,665 | $4,833 | $1,049 | $9,278 | 8 |
Showing top 50 of 5,807 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.